MedPath

MyKids: molecular profiling of non-rhabdomyosarcoma soft tissue sarcoma (NRSTS) in children, adolescents and young adults

Not Applicable
Conditions
on-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Cancer
Registration Number
ISRCTN12831761
Lead Sponsor
Princess Máxima Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
250
Inclusion Criteria

1. Patients within 2 months after new diagnosis of NRSTS
2. Age 0 - 25 years
3. Written informed consent by parents/legal representatives and patients 12 year and older
4. Minimal requirements for study participation: diagnostic FFPE material for WP2 or fresh frozen sample for WP1

Exclusion Criteria

1. Relapsed NRSTS, not included at diagnosis
2. No written informed consent

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath